Cormorant Asset Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Cormorant Asset Management’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,700,000	Closed	-$107M	–	66
2024 Q1	$107M	Buy	2,700,000 +150,000	+6%	+$4.43M	4.69%	4
2023 Q4	$48.6M	Buy	2,550,000 +650,000	+34%	+$9.03M	2.32%	9
2023 Q3	$21.8M	Buy	+1,900,000	New	+$23.4M	1.27%	20

Cormorant Asset Management's ALPN Position: Q2 2024 in Review

Cormorant Asset Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 2,700,000 shares — an estimated $107M sold.

Cormorant Asset Management first reported a position in ALPN in Q3 2023 and held it in 3 quarters. The position peaked at $107M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Cormorant Asset Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Cormorant Asset Management sold 2,700,000 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $107M.
Cormorant Asset Management first reported a position in Alpine Immune Sciences Inc in Q3 2023 and held it in 3 quarters.
Cormorant Asset Management's Alpine Immune Sciences Inc position peaked at $107M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Cormorant Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.